Red Tortoise LLC lifted its stake in Danaher Corporation (NYSE:DHR – Free Report) by 175.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 154 shares of the conglomerate’s stock after buying an additional 98 shares during the period. Red Tortoise LLC’s holdings in Danaher were worth $30,000 at the end of the most recent reporting period.
Other institutional investors have also bought and sold shares of the company. GHP Investment Advisors Inc. lifted its holdings in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 99 shares during the last quarter. Sierra Ocean LLC raised its position in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC acquired a new position in Danaher during the 1st quarter worth $31,000. Dunhill Financial LLC boosted its position in Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after buying an additional 67 shares during the last quarter. Finally, Costello Asset Management INC acquired a new stake in shares of Danaher in the 1st quarter valued at $41,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on DHR shares. Robert W. Baird upped their price target on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research note on Friday, July 18th. Wells Fargo & Company cut their target price on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 23rd. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a research report on Friday, July 11th. Guggenheim restated a “buy” rating and issued a $250.00 price objective on shares of Danaher in a report on Wednesday, July 23rd. Finally, Evercore ISI reduced their price objective on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 8th. Seventeen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $245.91.
Danaher Stock Performance
DHR stock opened at $215.05 on Monday. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.41. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The firm has a market cap of $153.98 billion, a PE ratio of 45.75, a P/E/G ratio of 3.06 and a beta of 0.77. The business’s 50-day moving average price is $200.19 and its two-hundred day moving average price is $197.24.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same quarter last year, the firm posted $1.72 earnings per share. Danaher’s revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s payout ratio is presently 27.23%.
Insider Buying and Selling at Danaher
In other news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.20% of the stock is owned by company insiders.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Defense Stocks Surging as Ukraine Tensions Deepen
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Starbucks Stock Slumps; This Competitor Shows Strength
- What Are Dividend Challengers?
- The Trade Desk: 2 Signs of a Comeback, 1 Risk Ahead
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.